NASDAQ · Drug Manufacturers - General

Gilead Sciences Inc (GILD)

$170.68 +3.06%
Add alert See all overbought stocks →
74 Overbought Daily RSI (14) · 30 Oct 2026

Moving averages

SMA 200$137.44+24.19%

Company profile

Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi.

SectorHealthcare
IndustryDrug Manufacturers - General
Market cap$186.53B
P/E ratioNone
EPS$-2.66
Beta0.332
Dividend yield2.13%
52-week high$154.51
52-week low$111.27

Similar stocks in Drug Manufacturers - General

PFE Pfizer Inc RSI 67 LLY Lilly(Eli) & Company RSI 78 JNJ Johnson & Johnson RSI 60 BMY Bristol-Myers Squibb Company RSI 55 NVO Novo Nordisk RSI 54 AMGN AMGEN Inc RSI 71 MRK Merck & Co Inc RSI 57 GSK GSK Plc RSI 51 ABBV Abbvie Inc RSI 73 OGN Organon & Company RSI 68
30 days of PRO Unlimited free, no card

RSI alerts for GILD

An email when GILD closes below RSI 30 or above 70. Nothing else.

Add alert

Data last updated 13 October 2026 at 8:52 PM EDT